NO900186L - Kondenserte benzazepiner. - Google Patents

Kondenserte benzazepiner.

Info

Publication number
NO900186L
NO900186L NO90900186A NO900186A NO900186L NO 900186 L NO900186 L NO 900186L NO 90900186 A NO90900186 A NO 90900186A NO 900186 A NO900186 A NO 900186A NO 900186 L NO900186 L NO 900186L
Authority
NO
Norway
Prior art keywords
benzazepiner
condensed
useful
benzazepines
hypertension
Prior art date
Application number
NO90900186A
Other languages
English (en)
Other versions
NO177264B (no
NO177264C (no
NO900186D0 (no
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO900186L publication Critical patent/NO900186L/no
Publication of NO900186D0 publication Critical patent/NO900186D0/no
Publication of NO177264B publication Critical patent/NO177264B/no
Publication of NO177264C publication Critical patent/NO177264C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO900186A 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten NO177264C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (4)

Publication Number Publication Date
NO900186L true NO900186L (no) 1990-01-12
NO900186D0 NO900186D0 (no) 1990-01-12
NO177264B NO177264B (no) 1995-05-08
NO177264C NO177264C (no) 1995-08-16

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900186A NO177264C (no) 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten

Country Status (13)

Country Link
EP (2) EP0363353B1 (no)
JP (1) JPH0678317B2 (no)
AT (1) ATE78467T1 (no)
AU (1) AU617651B2 (no)
DE (1) DE3780649T2 (no)
DK (1) DK162889C (no)
ES (1) ES2043623T3 (no)
FI (1) FI93212C (no)
GR (1) GR3006671T3 (no)
HU (1) HU203537B (no)
NO (1) NO177264C (no)
WO (1) WO1989000561A1 (no)
ZA (1) ZA875183B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
WO1991011437A1 (en) * 1990-02-02 1991-08-08 Schering Corporation 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
US7211574B2 (en) * 2002-08-29 2007-05-01 Schering Corporation Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
WO1987004430A2 (en) * 1986-01-16 1987-07-30 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
EP0299101A1 (en) 1989-01-18
ES2043623T3 (es) 1994-01-01
GR3006671T3 (no) 1993-06-30
JPH0678317B2 (ja) 1994-10-05
FI93212C (fi) 1995-03-10
DE3780649D1 (de) 1992-08-27
ZA875183B (en) 1988-04-08
FI93212B (fi) 1994-11-30
EP0363353B1 (en) 1992-07-22
DE3780649T2 (de) 1992-12-10
AU8037887A (en) 1989-02-13
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
DK9390A (da) 1990-03-12
DK9390D0 (da) 1990-01-12
JPH02504629A (ja) 1990-12-27
WO1989000561A1 (en) 1989-01-26
FI900175A0 (fi) 1990-01-12
HU203537B (en) 1991-08-28
NO900186D0 (no) 1990-01-12
AU617651B2 (en) 1991-12-05
DK162889C (da) 1992-05-11
EP0363353A1 (en) 1990-04-18
DK162889B (da) 1991-12-23
ATE78467T1 (de) 1992-08-15
EP0299101B1 (en) 1992-09-23

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
WO1987004430A3 (en) Fused benzazepines
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
EP0934748A3 (en) Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
MX9302414A (es) Proceso para la fabricacion de pirrolidinas (s)-3-amino-1- substituidas.
DK9390D0 (da) Kondenserede benzapiner
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
ZW18591A1 (en) 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)pyrroles
DE69018755D1 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE59309216D1 (de) Verfahren zur Herstellung von 2,4,5-Trifluorbenzonitril
DK598687D0 (da) Detergentkomposition
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
FR2376135A1 (fr) Aminoethoxy-3 pyrrolidines substituees en position 1, utiles comme medi
DE69107897D1 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
ES549983A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
DE69825325D1 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-t-Butylbiphenol
DE69500601D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.